Biomedical subjects

Genoveva Olaru

Publications and source records attributed to Genoveva Olaru.

3 recordsLinked to original sources

PubMed2006

[Combined surgery--cataract and glaucoma].

We present the case of a 70 years old female patient with bilateral senile cataract, more advanced at the RE; Primary open angle glaucoma, poor compensation with drugs at the RE (with timolol 0.5% and xalatan 0.005%). Combined cataract and glaucoma surgery was performed, using different surgical approach zones. The article describes the therapeutic options in the morbid association of cataract and glaucoma, pointing out the advantages and the indications for each method.

Aged↗

PubMed2006

[Our experience with Acrysof Natural intraocular lens].

UNLABELLED: The purpose of this paper is to appreciate the Acrysof Natural IOL comportment during the implantation after phacoemulsification, and to evaluate the visual acuity at 2 months and 2 years postoperative. MATERIAL AND METHODS: Prospective clinical study which comprises 48 patients( 48 eyes) with cataract operated on with phacoemulsification and implantation of Acrysof Natural IOL with the Monarch II injector and the implantation forceps. RESULTS: The patients' age was between 4- 82 years; The IOLs were introduced with the Monarch II injector in 47 cases and with the implantation forceps in 1 case; No IOL was damaged during the implantation; The unfolding and the rotation of the IOL were possible in all cases, without incidents; The visual acuity appreciated 2 months and 2 years postoperative was good in the most of the cases; the chromophore pigment did not influence the quality of vision and the color perception. CONCLUSIONS: The implantation of the Acrysof Natural IOL is identical with the implantation of the Acrysof single piece IOL, is easy to perform and completely atraumatic.

Acrylic Resins↗

PubMed2005

[Phacoemulsification with Advan-Tec system and Neosonix handpiece].

PURPOSE: The comparative analyses of the standard Legacy 20000 efficiency and the AdvanTec Legacy efficiency take into consideration the effective phacoemulsification time, power, and the postoperative clinical outcomes. MATERIAL AND METHODS: Retrospective clinical study which comprises 2 groups of patients operated on with phacoemulsification: 200 eyes were operated on using the classic handpiece of the Legacy 20000 system; 200 eyes were operated on using the AdvanTec Legacy system and the NeoSoniX handpiece. RESULTS: The effective phacoemulsification time in the standard Legacy group was under 0.4 min in 40 cases (20%), between 0.4-1.2 min in 120 cases (60%), and more than 1.2 min in 40 cases (20%). The effective phaco time in the AdvanTec-NeoSoniX group was under 0.4 min in 118 cases (59%), between 0.4-1.2 min in 72 cases (36%) and more than 1.2 min in 10 cases (5%). The mean phacoemulsification power varied between 19-38% in the first group and 14-22% in the second group. Descemetic striae and corneal edema on the first postoperative day were observed in 38 eyes (19%) in the Legacy standard group, and 18 eyes (9%) in the AvanTec-NeoSonix group. CONCLUSIONS: The progression from the standard Legacy to the AdvanTec Legacy system with NeoSoniX handpiece led to the reduction in phacoemulsification power by two mechanisms, oscillation, which breaks the nucleus, and vacuum, which removes and evacuates the nuclear material.

Aged↗